Psychedelic Stocks,Shroom News Mydecine Reports Annual Financial Results for 2020 By Dennis Mutua May 05, 2021 Biopharma and Life Sciences company dedicated to research, development and commercialization of innovative treatments to mental illness patients Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) has released its financial result...
Psychedelic Stocks,Shroom News Tryp Partners With Fluence to Provide Medical Therapy Training By Dennis Mutua May 04, 2021 Pharmaceutical company specializing on developing novel clinical stage compounds to treat orphan diseases and various mental conditions Tryp Therapeutics Inc. (CNSX: TRYP) (OTCQB: TRYPF) announced having entered a partnership with...
Featured,Shroom News,Spotlight Stock Lobe Life Sciences Files for Key PCT Application By Dennis Mutua April 30, 2021 Life sciences company specializing on psychedelics therapies for mental illness patients Lobe Life Sciences Ltd. (CSE: LOBE) (OTC: GTSIF) announced having submitted application for key Patent Cooperation Treaty (PCT) titled ‘Met...
Psychedelic Stocks,Shroom News Delix Therapeutics Releases Study Results Showing Therapeutic Potential for a Psychedelic Analogue Without Hallucinogenic Effects By Dennis Mutua April 29, 2021 Preclinical pharmaceutical company developing small molecule drug compound intended to assist providing therapies for mental illness patients Delix Therapeutics released results of a highly regarded scientific study. According ...
Psychedelic Stocks,Shroom News COMPASS Pathway Launches Public Offering of 4M American Depositary Shares By Dennis Mutua April 28, 2021 Mental healthcare company COMPASS Pathways PLC (CMPS) has launched a proposed public offering of 4 million American Depositary Shares (ADSs). Each of these ADSs will be representing one ordinary share of the company. In additio...
Psychedelic Stocks,Shroom News PsyBio and Miami University Extend Partnership For Extended Neuropsychiatric Drug Discovery By Dennis Mutua April 27, 2021 Therapeutics company developing biosynthetic psychoactive compounds for treatment of mental conditions PsyBio Therapeutics Corp. (CVE: PSYB) has extended its sponsored partnership agreement with Ohio based Miami University. The...
Featured,Shroom News Cambridge Health Alliance and Harvard Medical School Offering Training on Psychedelics By Dennis Mutua April 26, 2021 Innovative healthcare system Cambridge Health Alliance (CHA) and Harvard Medical School will be offering a continuing education course on psychedelics titled “Meditation and Psychotherapy: Learning from Non-Ordinary States”. ...
Psychedelic Stocks,Shroom News Silo Wellness Contemplating Uplisting On the Nasdaq Market By Dennis Mutua April 23, 2021 Health and wellness company focusing on psychedelics therapies Silo Wellness Inc. (OTCQB: SILO) is gearing up to secure an uplist to the Nasdaq capital market. The biotechnology company made the announcement after the company’s ...